Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PAI-1 haplogenotype confers genetic susceptibility for obesity and hypertriglyceridemia in Mexican children.

Investigacion clinica - 1 Sept 2016

de la Cruz-Mosso Ulises, Elena Ramos-Arellano Luz, Francisco Muñoz-Valle José, Berenice Salgado-Bernabé Aralia, Salgado-Goytia Lorenzo, Castro-Alarcón Natividad, Ramírez-Peralta Arturo, Parra-Rojas Isela

Abstract excerpt

The presence of childhood obesity predisposes to the development of cardiovascular and metabolic diseases, such as coronary artery disease and type 2 diabetes mellitus, in adulthood. The polymorphisms described in PAI-1 gene have been linked with obesity and metabolic syndrome in several populations. The aim of this study was to investigate the association of the -844 G/A (rs2227631), -675 4G/5G (rs1799889) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child
Share to Cross-Sectional Studies
Share to Genetic Predisposition to Disease
Share to Genotype
Share to Hypertriglyceridemia
Share to Mexico
Share to Pediatric Obesity
Share to Plasminogen Activator Inhibitor 1

Source

Identifiers

PMID: 29938477

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PAI-1 haplogenotype confers genetic susceptibility for obesity and hypertriglyceridemia in Mexican children.PMID 29938477Read ↗

Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.Semantic proximity Read ↗

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children.Semantic proximity Read ↗

Body adiposity but not insulin resistance is associated with -675 4G/5G polymorphism in the PAI-1 gene in a sample of Mexican children.Semantic proximity Read ↗

The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity.Semantic proximity Read ↗

PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.Semantic proximity Read ↗

Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters.Semantic proximity Read ↗

SIRT1 gene variants are related to risk of childhood obesity.Semantic proximity Read ↗

PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population.Semantic proximity Read ↗

Distribution of --844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations.Semantic proximity Read ↗

Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.Semantic proximity Read ↗

Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia.Semantic proximity Read ↗

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.